Showing 1 - 8 results of 8 for search 'Lisa Von Moltke', query time: 0.10s Refine Results
  1. 1
    Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan

    Physiologically‐Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan by Lei Sun, Lisa vonMoltke, Karen Rowland Yeo

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age

    Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age by Vipul Kumar, Hong Lu, Marjie Hard, Lisa von Moltke

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination tablet

    Using physiologically‐based pharmacokinetic modeling for predicting the effects of hepatic impairment on the pharmacokinetics of olanzapine and samidorphan given as a combination t... by Lei Sun, Zoe Barter, Lisa vonMoltke, Karen Rowland Yeo

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil

    Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole laurox... by Marjie L. Hard, Angela Wehr, Lisa von Moltke, Yangchun Du, Sarah Farwick, David P. Walling, John Sonnenberg

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection

    Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection by Stuart Cohen, Thomas Louie, Charles Berenson, Alpesh Amin, David Lombardi, Sissi Pham, Shirley Huang, Elaine Wang, Brooke Hasson, Barbara McGovern, Lisa Von Moltke

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI

    Integrated safety analysis of phase 3 studies for investigational microbiome therapeutic, SER-109, in recurrent CDI by Matthew Sims, Charles Berenson, Stuart Cohen, Elaine Wang, Elizabeth Hohmann, Richard Nathan, Alberto Odio, Paul Cook, Kelly Brady, David Lombardi, Asli Memisoglu, Ananya De, Brooke Hasson, Bret Lashner, Louis Korman, Doria Grimard, Juan Carlos Moises Gutierrez, Barbara McGovern, Lisa Von Moltke

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection

    Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection by Matthew Sims, Michael Silverman, Thomas Louie, Elaine Wang, Colleen Kraft, Mayur Ramesh, Tatiana Bogdanovich, Kelly Brady, David Lombardi, Asli Memisoglu, Ananya De, Brooke Hasson, Christine Lee, Paul Feuerstadt, Darrell Pardi, Colleen Kelly, Peter Daley, Godson Oguchi, Barbara McGovern, Lisa Von Moltke

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)

    SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI) by Sahil Khanna, Matthew Sims, Thomas J. Louie, Monika Fischer, Kerry LaPlante, Jessica Allegretti, Brooke R. Hasson, Allyson T. Fonte, Christopher McChalicher, David S. Ege, Jessica A. Bryant, Timothy J. Straub, Christopher B. Ford, Matthew R. Henn, Elaine E. L. Wang, Lisa von Moltke, Mark H. Wilcox

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: